Effects of intermittent T-cell cluster disaggregation on proliferative capacity and checkpoint marker expression
Background/aim: T-cell immunotherapies are rapidly gaining grounds in clinical success. Presently, there is first-to-market knowledge on the translation of research scale methods to clinical and commercial scales. Improved understanding can lead to more consistent and efficient production, scaling,...
Shranjeno v:
| Principais autores: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Taylor & Francis Group
2019-04-01
|
| Serija: | Autoimmunity |
| Teme: | |
| Online dostop: | http://dx.doi.org/10.1080/08916934.2019.1630064 |
| Oznake: |
Brez oznak, prvi označite!
|